New atypical epidemiological profile of parvovirus B19 revealed by molecular screening of blood donations, France, winter 2023/24-Reference-Cited by-同舟云学术

New atypical epidemiological profile of parvovirus B19 revealed by molecular screening of blood donations, France, winter 2023/24

Published:2024-05-23 Issue:21 Volume:29 Page:
ISSN:1560-7917
Container-title:Eurosurveillance
language:en
Short-container-title:

Author:

Guillet Marlène¹,Bas Ariane²,Lacoste Marjorie³,Ricard Céline⁴,Visse Catherine⁵,Barlet Valérie²,Malard Lucile⁶,Le Cam Sophie⁶,Morel Pascal⁶,de Lamballerie Xavier⁷,Laperche Syria⁶,Gallian Pierre⁷⁶^ORCID

Affiliation:

1. Etablissement Français du Sang Centre Pays de Loire, Nantes, France

2. Etablissement Français du Sang Auvergne Rhône Alpes, Lyon Décines, France

3. Etablissement Français du Sang Occitanie, Toulouse, France

4. Etablissement Français du Sang Hauts de France-Normandie, Loos, France

5. LFB – Biomédicaments, Control Laboratories, Courtaboeuf Cedex, France

6. Etablissement Français du Sang, La Plaine Saint-Denis, France.

7. Unité des Virus Émergents (UVE: Aix-Marseille Univ-Corsica Univ-IRD 190-Inserm 1207-IRBA), Marseille, France

Abstract

In France, blood donations are tested in pools of 96 samples for parvovirus B19 (B19V) DNA to discard plasma for fractionation when it contains high viral loads. Between January 2015 and March 2024, B19V-positive donations decreased during the COVID-19 pandemic, followed by a strong rebound in 2023 and unusually high circulation during winter 2023/24 (ca 10 times higher December 2023–March 2024 vs the pre-pandemic period). Variations over time are probably related to measures implemented to limit SARS-CoV-2 spread.

Publisher

European Centre for Disease Control and Prevention (ECDC)

Reference22 articles.

1. Parvovirus B19 viraemia in Dutch blood donors.;Zaaijer;Epidemiol Infect,2004

2. European Centre for Disease Prevention and Control (ECDC). Communicable disease threats report, 14-20 April 2024, week 16. Stockholm: ECDC; 2024. Available from: https://www.ecdc.europa.eu/en/publications-data/communicable-disease-threats-report-14-20-april-2024-week-16

3. Identification and characterization of persistent human erythrovirus infection in blood donor samples.;Candotti;J Virol,2004

4. Persistent infection by human parvovirus B19 in qualified blood donors.;Matsukura;Transfusion,2008

5. Parvovirus B19 DNA and antibodies in Chinese plasma donors, plasma pools and plasma derivatives.;Sun;PeerJ,2023

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical impact of recent surge in acute parvovirus B19 infections in Leicester UK, March–July 2024;Journal of Medical Virology;2024-09

2. Differential diagnosis on measles and rubella discarded cases highlights a sharp increase in parvovirus B19 infections in Milan, Northern Italy, in the first months of 2024;Journal of Medical Virology;2024-08-29

3. Unexpected high incidence of parvovirus B19 nucleic acid detection in German blood donors in the winter/spring season 2023/2024;Journal of Medical Virology;2024-08-29

4. Reassessing the Risk of Severe Parvovirus B19 Infection in the Immunocompetent Population: A Call for Vigilance in the Wake of Resurgence;Viruses;2024-08-24

5. An unusual outbreak of parvovirus B19 infections, France, 2023 to 2024;Eurosurveillance;2024-06-20